Improving prostate cancer diagnosis with special MRI
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a new type of MRI called CEST-MRI to better see prostate lesions. It may help find cancer more accurately than standard scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a high PSA level in your blood, which may mean prostate cancer
- You have not had chemotherapy, radiation therapy, or hormone therapy for prostate cancer yet
- You are willing and able to have an MRI scan
- You are not allergic to gadolinium (the dye used in some MRIs)
- You understand and read French well
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether having repeated MRI scans can help find prostate cancer early in men who have never had a biopsy. It may be a good fit if you have a slightly elevated PSA and a suspicious spot on your first MRI.
This study tests a new MRI-based method (called CEST) to help doctors better understand suspicious prostate areas before a biopsy, potentially improving accuracy and reducing unnecessary procedures.
This study tests whether new MRI imaging methods can better identify and grade prostate cancer in men with elevated PSA levels. You would get an MRI scan to help doctors see if cancer is present and how aggressive it might be.
This trial studies special MRI images to learn how well they can find prostate cancer before treatment. It may help doctors choose better next steps during biopsy or during active surveillance.
This study uses a special kind of MRI to better “map” prostate cancer inside the prostate. Researchers compare the MRI results with the detailed tissue exam after prostate surgery to see how accurate the imaging is.
This trial studies whether a special type of MRI during a PET/MRI scan (called CEST) can help doctors better evaluate brain tumors and tumor return after treatment. It may improve how well scans show where disease is before surgery or when tumors come back.
Hear when a new Suspected Prostate Cancer (increased PSA Level) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.